These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3602044

  • 1. Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin.
    Olgiati VR, Algeri S, Stramentinoli G.
    Pharmacol Res Commun; 1987 Mar; 19(3):231-40. PubMed ID: 3602044
    [Abstract] [Full Text] [Related]

  • 2. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M.
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract] [Full Text] [Related]

  • 3. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF, Salama AI.
    Eur J Pharmacol; 1986 Feb 18; 121(2):181-8. PubMed ID: 3699091
    [Abstract] [Full Text] [Related]

  • 4. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA, Rose S, Jenner P.
    Eur J Neurosci; 2001 Jan 18; 13(1):162-70. PubMed ID: 11135014
    [Abstract] [Full Text] [Related]

  • 5. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ, Korf J.
    Psychopharmacology (Berl); 1986 Jan 18; 90(1):54-7. PubMed ID: 3094062
    [Abstract] [Full Text] [Related]

  • 6. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL, Kilpatrick IC.
    Br J Pharmacol; 1996 May 18; 118(2):421-7. PubMed ID: 8735647
    [Abstract] [Full Text] [Related]

  • 7. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR, Emerich DF, el-Etri MM, Shipley MT, Zanol MD, Cahill DW, Norman AB.
    Pharmacol Biochem Behav; 1993 Oct 18; 46(2):303-7. PubMed ID: 8265684
    [Abstract] [Full Text] [Related]

  • 8. Effects of piracetam on the central dopaminergic transmission.
    Rägo LK, Allikmets LH, Zarkovsky AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec 18; 318(1):36-7. PubMed ID: 6276786
    [Abstract] [Full Text] [Related]

  • 9. The effect of phencyclidine on dopamine synthesis and metabolic in rat striatum.
    Doherty JD, Simonovic M, So R, Meltzer HY.
    Eur J Pharmacol; 1980 Jul 25; 65(2-3):139-49. PubMed ID: 7398783
    [Abstract] [Full Text] [Related]

  • 10. Tetrahydrobiopterin stimulates L-DOPA release from striatal tissue.
    Abreu-González P, González-Hernández T, Afonso-Oramas D, Cruz-Muros I, Barroso-Chinea P, González MC.
    Eur J Pharmacol; 2006 Jul 10; 541(1-2):33-7. PubMed ID: 16750826
    [Abstract] [Full Text] [Related]

  • 11. A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine.
    Wong PT, Teo WL, Lee T.
    Neuroreport; 1993 Oct 25; 5(1):53-6. PubMed ID: 7506588
    [Abstract] [Full Text] [Related]

  • 12. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L, Deng M, Zhang S, Fang Y, Li L.
    Clin Exp Pharmacol Physiol; 2014 Sep 25; 41(9):685-90. PubMed ID: 24910244
    [Abstract] [Full Text] [Related]

  • 13. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW, Slimovitch C, Toffano G.
    Br J Pharmacol; 1990 Apr 25; 99(4):741-9. PubMed ID: 2361171
    [Abstract] [Full Text] [Related]

  • 14. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR, Kim C.
    Res Commun Chem Pathol Pharmacol; 1978 Jul 25; 21(1):37-44. PubMed ID: 567367
    [Abstract] [Full Text] [Related]

  • 15. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T, Sharp T, Ungerstedt U.
    Eur J Pharmacol; 1984 Oct 30; 106(1):27-37. PubMed ID: 6085051
    [Abstract] [Full Text] [Related]

  • 16. Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats.
    Castelló ME, Bolioli B, Dajas F.
    Pharmacol Biochem Behav; 1992 Mar 30; 41(3):547-50. PubMed ID: 1584833
    [Abstract] [Full Text] [Related]

  • 17. Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid.
    Loeffler DA, LeWitt PA, DeMaggio AJ, Juneau PL, Milbury PE, Matson WR.
    J Neural Transm Park Dis Dement Sect; 1995 Mar 30; 9(1):45-53. PubMed ID: 7605589
    [Abstract] [Full Text] [Related]

  • 18. Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
    Hashitani T, Mizukawa K, Kumazaki M, Nishino H.
    Neurosci Res; 1998 Jan 30; 30(1):43-52. PubMed ID: 9572579
    [Abstract] [Full Text] [Related]

  • 19. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB, Rozitis A.
    Eur J Pharmacol; 1982 Feb 19; 78(1):113-5. PubMed ID: 7200429
    [Abstract] [Full Text] [Related]

  • 20. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
    Lannes B, Micheletti G, Warter JM, Kempf E, Di Scala G.
    Neurosci Lett; 1991 Jul 22; 128(2):177-81. PubMed ID: 1945038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.